A round of mixed financing involving 11 unnamed investors brought in $1 million for Aortica, an SEC filing showed. The company, which makes a technology that minimizes the need for invasive open surgeries for patients with juxtarenal aortic aneurysms, did not disclose how it intends to use the proceeds and is still seeking to raise nearly $3 million in the round.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.